People

Ben Dake

Ben Dake

Metastasis is the ultimate and fatal stage of breast cancer progression. Ben has developed a metastasis model to track seeding and outgrowth of human tumor cells systemically in immunocompromised mice by delivering cells intracardially. His work has examined potential roles for chromatin modifiers in metastasis, implicated endocrine messengers in colonization of the brain and adrenal […]

Read More →

Read More →

Jessica Elman

Jessica Elman

Our lab has shown that lineage-committed mammary epithelial cells can have bipotent character by stimulating luminal cells to adopt a basal phenotype. My project focuses on elucidating whether the reverse of this phenomenon can be induced, namely I aim to study whether basal cells can acquire a luminal phenotype.

Read More →

Read More →

Kayla Gross

Kayla Gross

Our lab focuses on investigating the molecular mechanisms that drive normal breast development and how these processes become disrupted in cancerous tissue. More specifically, we are interested in the role of stem and progenitor cells in both normal and carcinogenic development, especially the molecular drivers of breast epithelial differentiation. Previous work recently established the transcription […]

Read More →

Read More →

Wenhui Zhou

Read More →

Jerrica Breindel, Ph.D.

Read More →

Andrew DeCastro, Ph.D.

Read More →

Thomas K. Ni, Ph.D.

Thomas K. Ni, Ph.D.

American Cancer Society Postdoctoral Fellow

Read More →

Read More →

Ania Wronski, Ph.D.

Ania Wronski, Ph.D.

Over the past several years, genome sequencing has led to unparalleled, multifaceted analysis of the genetic and molecular landscape of human cancer, in particular breast cancer. Ideally, this information could enable medical professionals to make better decisions regarding treatment regimes. Perhaps the most exciting potential of this new personalised medicine era is the ability to […]

Read More →

Read More →

Charlotte Kuperwasser, Ph.D.

Charlotte Kuperwasser, Ph.D.

Dr. Charlotte Kuperwasser is the Director of the Raymond and Beverly Sackler Convergence Laboratory at Tufts University School of Medicine.

Read More →

Read More →

Andrew H. Beck, M.D., Ph.D.

Andrew H. Beck, M.D., Ph.D.

The goal of the Beck laboratory is to develop, apply, and integrate methods in molecular pathology, biomedical informatics, and computational image analysis for translational cancer research, leading to improved diagnostics and therapeutics for patients.

Read More →

Read More →

Top